Last 12 months
Inside the activity.
0 purchase rows · 5 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 12, 2020 Filed Aug 13, 2020 20:21 UTC |
VAN OORT DOUGLAS MDirector · Chairman and CEO
|
GiftCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-20-000183 · wf-form4_159735006197932.xml · nonDerivative · entry 4 VAN OORT DOUGLAS M · CIK 0001518733 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,262,790 F1 · kind: Mr. VanOort transferred these shares as a bona fide gift pursuant to a transaction exempt from Section 16(b) under Rule 16b-5. Read SEC document |
| August 11, 2020 Filed Aug 13, 2020 20:21 UTC |
VAN OORT DOUGLAS MDirector · Chairman and CEO
|
GiftCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-20-000183 · wf-form4_159735006197932.xml · nonDerivative · entry 3 VAN OORT DOUGLAS M · CIK 0001518733 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · Custodial Account for Child Disclosed balance after: 15,000 F2 · kind: Bona fide gift to an account held by Mr. VanOort's child for which Mr. VanOort is the custodian. Read SEC document |
| August 11, 2020 Filed Aug 13, 2020 20:21 UTC |
VAN OORT DOUGLAS MDirector · Chairman and CEO
|
GiftCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-20-000183 · wf-form4_159735006197932.xml · nonDerivative · entry 2 VAN OORT DOUGLAS M · CIK 0001518733 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,272,790 F2 · kind: Bona fide gift to an account held by Mr. VanOort's child for which Mr. VanOort is the custodian. Read SEC document |
| August 11, 2020 Filed Aug 13, 2020 20:21 UTC |
VAN OORT DOUGLAS MDirector · Chairman and CEO
|
GiftCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-20-000183 · wf-form4_159735006197932.xml · nonDerivative · entry 1 VAN OORT DOUGLAS M · CIK 0001518733 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,277,790 F1 · kind: Mr. VanOort transferred these shares as a bona fide gift pursuant to a transaction exempt from Section 16(b) under Rule 16b-5. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 22:22 UTC |
HANNAH ALISON L.Director
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $7.27 | $0.00 |
DisclosureSEC source: 0001077183-20-000181 · wf-form4_159709812032905.xml · derivative · entry 2 HANNAH ALISON L. · CIK 0001645600 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2022-05-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On May 25, 2017, Alison Hannah was granted 10,000 stock options. The options vested ratably on the next three anniversary dates of the grant date. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 22:22 UTC |
HANNAH ALISON L.Director
|
Exercise / conversionCommon Stock | 10,000 | $7.27 | $72,700.00 |
DisclosureSEC source: 0001077183-20-000181 · wf-form4_159709812032905.xml · nonDerivative · entry 1 HANNAH ALISON L. · CIK 0001645600 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,796 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 22:19 UTC |
CARDOZA GEORGEPresident, Pharma Services
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $7.15 | $0.00 |
DisclosureSEC source: 0001077183-20-000180 · wf-form4_159709796772215.xml · derivative · entry 4 CARDOZA GEORGE · CIK 0001518734 · President, Pharma Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 100,000 shares Expires 2021-04-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On April 20, 2016, Mr. Cardoza was granted 200,000 stock options. These options vested ratably over the first three anniversary dates of the grant date. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 22:19 UTC |
CARDOZA GEORGEPresident, Pharma Services
|
SaleCommon Stock | 82,500 | $39.35 | $3,246,375.00 |
DisclosureSEC source: 0001077183-20-000180 · wf-form4_159709796772215.xml · nonDerivative · entry 3 CARDOZA GEORGE · CIK 0001518734 · President, Pharma Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 350,902 Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 22:19 UTC |
CARDOZA GEORGEPresident, Pharma Services
|
Exercise / conversionCommon Stock | 100,000 | $7.15 | $715,000.00 |
DisclosureSEC source: 0001077183-20-000180 · wf-form4_159709796772215.xml · nonDerivative · entry 2 CARDOZA GEORGE · CIK 0001518734 · President, Pharma Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 433,402 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 03, 2020 Filed Aug 4, 2020 22:33 UTC |
Bonello WilliamPresident, Informatics
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,964 | $0.00 Strike: $8.03 | $0.00 |
DisclosureSEC source: 0001077183-20-000177 · wf-form4_159658021934813.xml · derivative · entry 5 Bonello William · CIK 0001454941 · President, Informatics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,370 Underlying: Common Stock · 1,964 shares Expires 2023-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: On February 26, 2018, Mr. Bonello was granted 120,500 stock options. These options vest ratably over the first three anniversary dates of the grant date. Read SEC document |
| August 03, 2020 Filed Aug 4, 2020 22:33 UTC |
Bonello WilliamPresident, Informatics
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 20,036 | $0.00 Strike: $7.52 | $0.00 |
DisclosureSEC source: 0001077183-20-000177 · wf-form4_159658021934813.xml · derivative · entry 4 Bonello William · CIK 0001454941 · President, Informatics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,727 Underlying: Common Stock · 20,036 shares Expires 2022-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On April 28, 2017, Mr. Bonello was granted 100,000 stock options. These options vested ratably over the first three anniversary dates of the grant date. Read SEC document |
| August 03, 2020 Filed Aug 4, 2020 22:33 UTC |
Bonello WilliamPresident, Informatics
|
SaleCommon Stock | 22,000 | $38.61 | $849,420.00 |
DisclosureSEC source: 0001077183-20-000177 · wf-form4_159658021934813.xml · nonDerivative · entry 3 Bonello William · CIK 0001454941 · President, Informatics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,060 Read SEC document |
| August 03, 2020 Filed Aug 4, 2020 22:33 UTC |
Bonello WilliamPresident, Informatics
|
Exercise / conversionCommon Stock | 1,964 | $8.03 | $15,770.92 |
DisclosureSEC source: 0001077183-20-000177 · wf-form4_159658021934813.xml · nonDerivative · entry 2 Bonello William · CIK 0001454941 · President, Informatics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,060 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 03, 2020 Filed Aug 4, 2020 22:33 UTC |
Bonello WilliamPresident, Informatics
|
Exercise / conversionCommon Stock | 20,036 | $7.52 | $150,670.72 |
DisclosureSEC source: 0001077183-20-000177 · wf-form4_159658021934813.xml · nonDerivative · entry 1 Bonello William · CIK 0001454941 · President, Informatics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,096 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 03, 2020 Filed Aug 4, 2020 22:01 UTC |
BALLIET JENNIFERVP and Chief Culture Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 13,000 | $0.00 Strike: $7.52 | $0.00 |
DisclosureSEC source: 0001077183-20-000175 · wf-form4_159657837366924.xml · derivative · entry 3 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,000 Underlying: Common Stock · 13,000 shares Expires 2022-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On April 28, 2017, Ms. Balliet was granted 60,000 stock options. These options vest ratably over the first three anniversaries of the grant date. Read SEC document |
| August 03, 2020 Filed Aug 4, 2020 22:01 UTC |
BALLIET JENNIFERVP and Chief Culture Officer
|
SaleCommon Stock | 13,000 | $39.25 | $510,250.00 |
DisclosureSEC source: 0001077183-20-000175 · wf-form4_159657837366924.xml · nonDerivative · entry 2 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,980 Read SEC document |
| August 03, 2020 Filed Aug 4, 2020 22:01 UTC |
BALLIET JENNIFERVP and Chief Culture Officer
|
Exercise / conversionCommon Stock | 13,000 | $7.52 | $97,760.00 |
DisclosureSEC source: 0001077183-20-000175 · wf-form4_159657837366924.xml · nonDerivative · entry 1 BALLIET JENNIFER · CIK 0001640500 · VP and Chief Culture Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,980 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2020 Filed Aug 4, 2020 21:47 UTC |
VAN OORT DOUGLAS MDirector · Chairman and CEO
|
Tax withholdingCommon Stock | 5,953 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-20-000173 · wf-form4_159657754692322.xml · nonDerivative · entry 2 VAN OORT DOUGLAS M · CIK 0001518733 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,287,790 F1 · shares: Shares surrendered to NeoGenomics Inc. to satisfy the tax obligations in connection with the August 1, 2020 vesting of restricted stock. Read SEC document |
| July 30, 2020 Filed Aug 3, 2020 23:26 UTC |
SHOVLIN ROBERT J.President, Clinical Services
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 16,724 | $0.00 Strike: $19.60 | $0.00 |
DisclosureSEC source: 0001077183-20-000171 · wf-form4_159649719309566.xml · derivative · entry 5 SHOVLIN ROBERT J. · CIK 0001621453 · President, Clinical Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,173 Underlying: Common Stock · 16,724 shares Expires 2024-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: On March 1, 2019, Mr. Shovlin was granted 66,897 stock options. These options vest ratably over the first four anniversary dates of the grant date. Read SEC document |
| July 30, 2020 Filed Aug 3, 2020 23:26 UTC |
SHOVLIN ROBERT J.President, Clinical Services
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 66,667 | $0.00 Strike: $7.52 | $0.00 |
DisclosureSEC source: 0001077183-20-000171 · wf-form4_159649719309566.xml · derivative · entry 4 SHOVLIN ROBERT J. · CIK 0001621453 · President, Clinical Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 66,667 shares Expires 2022-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On April 28, 2017, Mr. Shovlin was granted 200,000 stock options. These options vest ratably over the first three anniversary dates of the grant date. Read SEC document |
| July 30, 2020 Filed Aug 3, 2020 23:26 UTC |
SHOVLIN ROBERT J.President, Clinical Services
|
SaleCommon Stock | 81,356 | $38.17 | $3,105,358.52 |
DisclosureSEC source: 0001077183-20-000171 · wf-form4_159649719309566.xml · nonDerivative · entry 3 SHOVLIN ROBERT J. · CIK 0001621453 · President, Clinical Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,270 Read SEC document |
| July 30, 2020 Filed Aug 3, 2020 23:26 UTC |
SHOVLIN ROBERT J.President, Clinical Services
|
Exercise / conversionCommon Stock | 16,724 | $19.60 | $327,790.40 |
DisclosureSEC source: 0001077183-20-000171 · wf-form4_159649719309566.xml · nonDerivative · entry 2 SHOVLIN ROBERT J. · CIK 0001621453 · President, Clinical Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229,626 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 30, 2020 Filed Aug 3, 2020 23:26 UTC |
SHOVLIN ROBERT J.President, Clinical Services
|
Exercise / conversionCommon Stock | 66,667 | $7.52 | $501,335.84 |
DisclosureSEC source: 0001077183-20-000171 · wf-form4_159649719309566.xml · nonDerivative · entry 1 SHOVLIN ROBERT J. · CIK 0001621453 · President, Clinical Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 212,902 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 30, 2020 Filed Aug 3, 2020 22:43 UTC |
Kelly Michael AaronDirector
|
GrantStock Option (Right to Buy) · Derivative | 2,223 | $0.00 Strike: $37.53 | $0.00 |
DisclosureSEC source: 0001077183-20-000169 · wf-form4_159649458478191.xml · derivative · entry 2 Kelly Michael Aaron · CIK 0001769668 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,223 Underlying: Common Stock · 2,223 shares Expires 2027-05-28 Read SEC document |
| July 30, 2020 Filed Aug 3, 2020 22:43 UTC |
Kelly Michael AaronDirector
|
GrantCommon Stock | 1,782 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-20-000169 · wf-form4_159649458478191.xml · nonDerivative · entry 1 Kelly Michael Aaron · CIK 0001769668 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,782 Read SEC document |
| June 22, 2020 Filed Jun 23, 2020 21:07 UTC |
Dieter Cynthia JChief Accounting Officer
|
GrantStock Option (Right to Buy) · Derivative | 3,968 | $0.00 Strike: $28.35 | $0.00 |
DisclosureSEC source: 0001077183-20-000148 · wf-form4_159294644167841.xml · derivative · entry 2 Dieter Cynthia J · CIK 0001815335 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,968 Underlying: Common Stock · 3,968 shares Expires 2027-06-22 F1 · derivative.exercise_date: On June 22, 2020, Ms. Dieter was granted 3,968 stock options. These options vest ratably over the first four anniversary dates of the grant date. Read SEC document |
| June 22, 2020 Filed Jun 23, 2020 21:07 UTC |
Dieter Cynthia JChief Accounting Officer
|
GrantCommon Stock | 605 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-20-000148 · wf-form4_159294644167841.xml · nonDerivative · entry 1 Dieter Cynthia J · CIK 0001815335 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 605 Read SEC document |
| May 28, 2020 Filed Jun 1, 2020 23:38 UTC |
HANNAH ALISON L.Director
|
GrantStock Options (Right to Buy) · Derivative | 3,448 | $0.00 Strike: $28.54 | $0.00 |
DisclosureSEC source: 0001077183-20-000135 · wf-form4_159105466369083.xml · derivative · entry 5 HANNAH ALISON L. · CIK 0001645600 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,448 Underlying: Common Stock · 3,448 shares Expires 2027-05-28 Read SEC document |
| May 28, 2020 Filed Jun 1, 2020 23:38 UTC |
HANNAH ALISON L.Director
|
GrantCommon Stock | 2,698 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-20-000135 · wf-form4_159105466369083.xml · nonDerivative · entry 1 HANNAH ALISON L. · CIK 0001645600 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,796 Read SEC document |
| May 28, 2020 Filed Jun 1, 2020 22:58 UTC |
KANOVSKY STEPHEN MDirector
|
GrantStock Options (Right to Buy) · Derivative | 3,448 | $0.00 Strike: $28.54 | $0.00 |
DisclosureSEC source: 0001077183-20-000134 · wf-form4_159105226356124.xml · derivative · entry 3 KANOVSKY STEPHEN M · CIK 0001713090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,448 Underlying: Common Stock · 3,448 shares Expires 2027-05-28 Read SEC document |
| May 28, 2020 Filed Jun 1, 2020 22:58 UTC |
KANOVSKY STEPHEN MDirector
|
GrantCommon Stock | 2,698 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-20-000134 · wf-form4_159105226356124.xml · nonDerivative · entry 1 KANOVSKY STEPHEN M · CIK 0001713090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,117 Read SEC document |
| May 28, 2020 Filed Jun 1, 2020 22:57 UTC |
TETRAULT LYNN A.Director
|
GrantStock Options (Right to Buy) · Derivative | 3,448 | $0.00 Strike: $28.54 | $0.00 |
DisclosureSEC source: 0001077183-20-000133 · wf-form4_159105224012827.xml · derivative · entry 6 TETRAULT LYNN A. · CIK 0001645512 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,448 Underlying: Common Stock · 3,448 shares Expires 2027-05-28 Read SEC document |
| May 28, 2020 Filed Jun 1, 2020 22:57 UTC |
TETRAULT LYNN A.Director
|
GrantCommon Stock | 2,698 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-20-000133 · wf-form4_159105224012827.xml · nonDerivative · entry 1 TETRAULT LYNN A. · CIK 0001645512 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,351 Read SEC document |
| May 28, 2020 Filed Jun 1, 2020 22:57 UTC |
HIPP RAYMOND RDirector
|
GrantStock Options (Right to Buy) · Derivative | 3,448 | $0.00 Strike: $28.54 | $0.00 |
DisclosureSEC source: 0001077183-20-000132 · wf-form4_159105221595007.xml · derivative · entry 4 HIPP RAYMOND R · CIK 0001188214 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,448 Underlying: Common Stock · 3,448 shares Expires 2027-05-28 Read SEC document |
| May 28, 2020 Filed Jun 1, 2020 22:57 UTC |
HIPP RAYMOND RDirector
|
GrantCommon Stock | 2,698 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-20-000132 · wf-form4_159105221595007.xml · nonDerivative · entry 1 HIPP RAYMOND R · CIK 0001188214 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,800 Read SEC document |
| May 28, 2020 Filed Jun 1, 2020 22:56 UTC |
Johnson Kevin CDirector
|
GrantStock Options (Right to Buy) · Derivative | 3,448 | $0.00 Strike: $28.54 | $0.00 |
DisclosureSEC source: 0001077183-20-000131 · wf-form4_159105219357048.xml · derivative · entry 4 Johnson Kevin C · CIK 0001353436 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,448 Underlying: Common Stock · 3,448 shares Expires 2027-05-28 Read SEC document |
| May 28, 2020 Filed Jun 1, 2020 22:56 UTC |
Johnson Kevin CDirector
|
GrantCommon Stock | 2,698 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-20-000131 · wf-form4_159105219357048.xml · nonDerivative · entry 1 Johnson Kevin C · CIK 0001353436 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,666 Read SEC document |
| May 28, 2020 Filed Jun 1, 2020 22:56 UTC |
CROWTHER BRUCE KDirector
|
GrantStock Options (Right to Buy) · Derivative | 3,448 | $0.00 Strike: $28.54 | $0.00 |
DisclosureSEC source: 0001077183-20-000130 · wf-form4_159105217191512.xml · derivative · entry 6 CROWTHER BRUCE K · CIK 0001244274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,448 Underlying: Common Stock · 3,448 shares Expires 2027-05-28 Read SEC document |
| May 28, 2020 Filed Jun 1, 2020 22:56 UTC |
CROWTHER BRUCE KDirector
|
GrantCommon Stock | 2,698 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-20-000130 · wf-form4_159105217191512.xml · nonDerivative · entry 1 CROWTHER BRUCE K · CIK 0001244274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,883 Read SEC document |
| May 28, 2020 Filed Jun 1, 2020 22:56 UTC |
JONES STEVEN CDirector
|
GrantStock Options (Right to Buy) · Derivative | 3,448 | $0.00 Strike: $28.54 | $0.00 |
DisclosureSEC source: 0001077183-20-000129 · wf-form4_159105214951321.xml · derivative · entry 10 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,448 Underlying: Common Stock · 3,448 shares Expires 2027-05-28 Read SEC document |
| May 28, 2020 Filed Jun 1, 2020 22:56 UTC |
JONES STEVEN CDirector
|
GrantCommon Stock | 2,698 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-20-000129 · wf-form4_159105214951321.xml · nonDerivative · entry 5 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197,932 Read SEC document |
| May 28, 2020 Filed Jun 4, 2020 22:45 UTC |
Stahler Rachel ADirector
|
GrantStock Option (Right to Buy) · Derivative | 3,448 | $0.00 Strike: $28.54 | $0.00 |
DisclosureSEC source: 0001077183-20-000141 · wf-form4_159131069488504.xml · derivative · entry 2 Stahler Rachel A · CIK 0001679854 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,448 Underlying: Common Stock · 3,448 shares Expires 2027-05-28 Read SEC document |
| May 28, 2020 Filed Jun 4, 2020 22:45 UTC |
Stahler Rachel ADirector
|
GrantCommon Stock | 2,698 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-20-000141 · wf-form4_159131069488504.xml · nonDerivative · entry 1 Stahler Rachel A · CIK 0001679854 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,698 Read SEC document |
| May 25, 2020 Filed May 27, 2020 21:24 UTC |
VAN OORT DOUGLAS MDirector · Chairman and CEO
|
Tax withholdingCommon Stock | 22,330 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-20-000118 · wf-form4_159061466388858.xml · nonDerivative · entry 2 VAN OORT DOUGLAS M · CIK 0001518733 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,293,743 F1 · shares: Shares surrendered to NeoGenomics Inc. to satisfy the tax obligations in connection with the May 25, 2020 vesting of restricted stock. Read SEC document |
| May 25, 2020 Filed May 27, 2020 21:20 UTC |
SHOVLIN ROBERT J.President, Clinical Services
|
Tax withholdingCommon Stock | 5,405 | $0.00 | $0.00 |
DisclosureSEC source: 0001077183-20-000116 · wf-form4_159061438885210.xml · nonDerivative · entry 1 SHOVLIN ROBERT J. · CIK 0001621453 · President, Clinical Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,235 F1 · shares: Shares surrendered to NeoGenomics Inc. to satisfy the tax obligations in connection with the May 25, 2020 vesting of restricted stock. Read SEC document |
| May 01, 2020 Filed May 4, 2020 21:34 UTC |
CROWTHER BRUCE KDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $4.78 | $0.00 |
DisclosureSEC source: 0001077183-20-000110 · wf-form4_158862808205250.xml · derivative · entry 2 CROWTHER BRUCE K · CIK 0001244274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2020-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On May 6, 2015 Mr. Crowther was granted 10,000 stock options. The options vest ratably over the first three anniversary dates of the grant date. Read SEC document |
| May 01, 2020 Filed May 4, 2020 21:34 UTC |
CROWTHER BRUCE KDirector
|
Exercise / conversionCommon Stock | 10,000 | $4.78 | $47,800.00 |
DisclosureSEC source: 0001077183-20-000110 · wf-form4_158862808205250.xml · nonDerivative · entry 1 CROWTHER BRUCE K · CIK 0001244274 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,185 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 13, 2020 Filed Mar 16, 2020 22:45 UTC |
JONES STEVEN CDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 125,000 | $0.00 Strike: $4.78 | $0.00 |
DisclosureSEC source: 0001077183-20-000049 · wf-form4_158439873738000.xml · derivative · entry 6 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Opportunity Fund Disclosed balance after: 0 Underlying: Common Stock · 125,000 shares Expires 2020-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: On May 4, 2015, Mr. Jones was granted 225,000 stock options. These options vest ratably over the first three anniversary dates of the grant date. F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| March 13, 2020 Filed Mar 16, 2020 22:45 UTC |
JONES STEVEN CDirector
|
Exercise / conversionCommon Stock | 125,000 | $4.78 | $597,500.00 |
DisclosureSEC source: 0001077183-20-000049 · wf-form4_158439873738000.xml · nonDerivative · entry 1 JONES STEVEN C · CIK 0001518732 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Aspen Select Opportunity Fund Disclosed balance after: 1,500,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein. Read SEC document |
| March 04, 2020 Filed Mar 6, 2020 01:14 UTC |
SHOVLIN ROBERT J.President, Clinical Services
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 96,167 | $0.00 Strike: $8.03 | $0.00 |
DisclosureSEC source: 0001077183-20-000047 · wf-form4_158345723213644.xml · derivative · entry 3 SHOVLIN ROBERT J. · CIK 0001621453 · President, Clinical Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,167 Underlying: Common Stock · 96,167 shares Expires 2023-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On February 26, 2018, Mr. Shovlin was granted 288,500 stock options. These options vest ratably over the first three anniversary dates of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.